Albireo Pharma, Inc.(ALBO),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community

At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.

Close

ALBO Albireo Pharma, Inc.

Market Closed 12-12 16:00:00 EST

44.15

+0.00

0.00%

High44.15	Low44.15	Vol0.00
Open44.15	D1 Closing44.15	Amplitude0.00%
Mkt Cap913.96M	Tradable Cap756.60M	Total Shares20.70M
T/O0.00	T/O Rate0.00%	Tradable Shares17.14M
P/B--	ROE--	EPS0.00
52wk High--	52wk Low--	P/E--
Dividend--	Div.Yield--	ROA--

Loading ...

{"stockData":{"symbol":"ALBO","market":"US","secType":"STK","nameCN":"Albireo Pharma, Inc.","latestPrice":44.15,"timestamp":1765573200000,"preClose":44.15,"halted":0,"volume":0,"delay":0,"floatShares":17137043,"shares":20701283,"eps":-6.733651,"marketStatus":"Market Closed","change":0,"latestTime":"12-12 16:00:00 EST","open":44.15,"high":44.15,"low":44.15,"amount":0,"amplitude":0,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-6.733651,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1765789200000},"marketStatusCode":7,"adr":0,"adrRate":0,"listingDate":1478232000000,"exchange":"NASDAQ","adjPreClose":44.15,"volumeRatio":0,"impliedVol":0.1518,"impliedVolPercentile":0},"requestUrl":"/m/hq/s/ALBO","defaultTab":"news","newsList":[],"profile":{"websiteUrl":"http://www.albireopharma.com","stockEarnings":[{"period":"1week","weight":0},{"period":"1month","weight":0},{"period":"3month","weight":0},{"period":"6month","weight":0},{"period":"1year","weight":0},{"period":"ytd","weight":0}],"compareEarnings":[{"period":"1week","weight":-0.0057},{"period":"1month","weight":-0.0024},{"period":"3month","weight":0.037},{"period":"6month","weight":0.142},{"period":"1year","weight":0.1281},{"period":"ytd","weight":0.1633}],"compareStock":{"symbol":"SPY","name":"SPDR S&P 500 ETF Trust"},"description":"Albireo Pharma, Inc., a commercial-stage biopharmaceutical company, focuses on the development and commercialization of novel bile acid modulators to treat orphan pediatric liver diseases and other liver or gastrointestinal diseases and disorders. The company offers Bylvay for the treatment of progressive familial intrahepatic cholestasis, as well as in Phase III clinical trial for treating biliary atresia, alagille syndrome, and rare and life-threatening disorder to children; and Elobixibat for the treatment of chronic constipation and other functional diseases. It also engages in the developing of A3907, which is in Phase I clinical trial for the treatment of adult liver diseases; and A2342, a preclinical candidate to treat adult viral and liver diseases. The company has a license agreement with EA Pharma Co., Ltd. for the development and commercialization of elobixibat. Albireo Pharma, Inc. is headquartered in Boston, Massachusetts. As of March 1, 2023, Albireo Pharma, Inc. operates as a subsidiary of Ipsen Biopharmaceuticals, Inc..","yearOnYearQuotes":[{"month":1,"riseRate":0.555556,"avgChangeRate":0.188247},{"month":2,"riseRate":0.444444,"avgChangeRate":0.05798},{"month":3,"riseRate":0.222222,"avgChangeRate":-0.041275},{"month":4,"riseRate":0.333333,"avgChangeRate":0.024296},{"month":5,"riseRate":0.333333,"avgChangeRate":-0.018845},{"month":6,"riseRate":0.333333,"avgChangeRate":0.017446},{"month":7,"riseRate":0.333333,"avgChangeRate":-0.020688},{"month":8,"riseRate":0.333333,"avgChangeRate":-0.006747},{"month":9,"riseRate":0.333333,"avgChangeRate":-0.006109},{"month":10,"riseRate":0.222222,"avgChangeRate":-0.002602},{"month":11,"riseRate":0.333333,"avgChangeRate":0.02361},{"month":12,"riseRate":0.3,"avgChangeRate":-0.029388}],"exchange":"NASDAQ","name":"Albireo Pharma, Inc.","nameEN":"Albireo Pharma, Inc."},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"deviceId":"web-server-community-laohu8-v3","version":"4.35.11","shortVersion":"4.35.11","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Albireo Pharma, Inc.(ALBO),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","description":"Find the latest Albireo Pharma, Inc.(ALBO) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","keywords":"Albireo Pharma, Inc.,ALBO,Albireo Pharma, Inc.股票,Albireo Pharma, Inc.股票老虎,Albireo Pharma, Inc.股票老虎国际,Albireo Pharma, Inc.行情,Albireo Pharma, Inc.股票行情,Albireo Pharma, Inc.股价,Albireo Pharma, Inc.股市,Albireo Pharma, Inc.股票价格,Albireo Pharma, Inc.股票交易,Albireo Pharma, Inc.股票购买,Albireo Pharma, Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Albireo Pharma, Inc.(ALBO),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","og_description":"Find the latest Albireo Pharma, Inc.(ALBO) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","og_image":"https://community-static.tradeup.com/news/9b6dafd60190235ae8e2c95f52c583a0"}}}

Introduction